Hepion Pharmaceuticals Stock (NASDAQ: HEPA) stock price, news, charts, stock research, profile.
Open | $1.07 |
Close | - |
Volume / Avg. | 15.01K / 38.31K |
Day Range | 1.02 - 1.07 |
52 Wk Range | 0.90 - 11.07 |
Market Cap | $5.60M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 39 |
Short Interest | 0.28% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Hepion Pharmaceuticals (NASDAQ:HEPA) through any online brokerage.
Other companies in Hepion Pharmaceuticals’s space includes: Kiora Pharmaceuticals (NASDAQ:KPRX), Universe Pharmaceuticals (NASDAQ:UPC), Akanda (NASDAQ:AKAN), Palisade Bio (NASDAQ:PALI) and Sonoma Pharmaceuticals (NASDAQ:SNOA).
There is no analysis for Hepion Pharmaceuticals.
Hepion Pharmaceuticals has a consensus price target of $1.75.
The stock price for Hepion Pharmaceuticals (NASDAQ: HEPA) is $1.0239 last updated Today at June 28, 2024 at 11:35 AM EDT.
There are no upcoming dividends for Hepion Pharmaceuticals.
Hepion Pharmaceuticals’s Q2 earnings are confirmed for Monday, August 12, 2024.
There is no upcoming split for Hepion Pharmaceuticals.
Hepion Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.